It’s Gavin Newsom’s final year in office as California governor — and his last chance to use his role as governor to audition ...
State Rep. Jason Thompson is hosting three pre-session town halls for constituents ahead of the 2026 General Legislative ...
Drawing on his experience as a firefighter and local organizer, Forstag spoke during the “Fighting Oligarghy” rally led by U.S. Sen. Bernie Sanders and U.S. Rep. Alexandria Ocasio-Cortez in Missoula ...
President Donald Trump's administration said Monday that it's planning to tighten rules for federal child care funds after a series of alleged fraud schemes at Minnesota day care centers run ...
Citigroup stock now trades in line with money center banks and looks priced for perfection as forecasts stay aggressive.
On Dec. 22, Teton County officials passed a motion employing a proposed runaway and beyond parental control ordinance, presented with the condition that legal review and information be presented from ...
DNA origami cages constrain individual proteins toward preferred orientations on electrodes, dramatically improving ...
Abstract: Over the past few decades, the field of metaheuristics optimization has undergone rapid development. More than 650 different metaheuristic algorithms have been created so far. Among these, ...
Solve Intelligence, the AI platform for the $200B+ patent industry, has raised $40M in Series B funding and is launching a new product for generating patent claim charts. Solve’s Series B comes just ...
The new round, which follows a $12 million Series A earlier this year, includes participation from Thomson Reuters and the founder of Quinn Emanuel’s IP litigation practice. Solve Intelligence ...
An engineer for New York Times Games has been trying to teach artificial intelligence to understand wordplay more like a human. By Shafik Quoraishee Shafik Quoraishee is a machine-learning engineer ...
A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...